SEC EDGARSEP 101 min read$EL

BARSHEFSKY CHARLENE sold $373K of EL (indirect holdings)

BARSHEFSKY CHARLENE sold 3,775 indirectly-held shares of ESTEE LAUDER COMPANIES INC (EL) at $98.82 ($0.37M total) on 2026-09-09.

Original reporting

SEC EDGAR · BARSHEFSKY CHARLENE

Published Sep 10, 2026, 8:42 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 10, 2026, 8:51 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$EL

Neutral

medium confidence

Mentioned

$EL

Relevance

4/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$ELNeutralLow

Why it matters

The disclosed sale is modest and unlikely to affect EL's price materially.

Market read

Routine insider sale with limited trading relevance.

What to watch

The sale is part of a larger indirect holding; overall insider ownership remains substantial.

Relevance 4/10Novelty 4/10Timing: Filed after market close on 2026-09-09

Background

SEC Form 4 filings disclose insider transactions; traders monitor them for signals.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$ELNeutralMedium confidence

Context

Director Charene Barshefsky sold 3,775 shares of Estée Lauder (EL) for $373,045, reducing her stake to 50,971 shares.

Expected impact

Minor downward pressure, likely within normal trading noise.

Evidence & confidence

Insider sales under $1M by a director are routine and rarely move the stock significantly.

Market effects

Sector

No broader sector impact; typical insider transaction.

Regional

Limited to U.S. investors tracking Estée Lauder.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

If the director anticipates near-term weakness, the sale could hint at downside risk.

Key entities

Company
Estée Lauder Companies Inc
US-listed cosmetics and beauty products company (ticker EL).
Individual
Charene Barshefsky
Director of Estée Lauder.

Read at source ← All news

SEP 15

$ELLow

FRIBOURG PAUL J sold $10.0M of EL (indirect holdings)

FRIBOURG PAUL J sold 103,000 indirectly-held shares of ESTEE LAUDER COMPANIES INC (EL) at an average of $97.56 ($96.78–$98.79, $10.05M total) across 4 trades over 2026-09-11 to 2026-09-14.

SEC EDGAR1 min

SEP 15

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min

AUG 28

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min

AUG 28

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min

AUG 27

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min